[勘误]上皮-间充质转化是获得性顺铂耐药的必要条件,并增加鼻咽癌细胞的转移潜能。

IF 5.8 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
International journal of molecular medicine Pub Date : 2025-10-01 Epub Date: 2025-07-25 DOI:10.3892/ijmm.2025.5591
Pei Zhang, Hao Liu, Fei Xia, Qian Wen Zhang, Yuan Yuan Zhang, Qing Zhao, Zhen Hua Chao, Zhi Wen Jiang, Chen Chen Jiang
{"title":"[勘误]上皮-间充质转化是获得性顺铂耐药的必要条件,并增加鼻咽癌细胞的转移潜能。","authors":"Pei Zhang, Hao Liu, Fei Xia, Qian Wen Zhang, Yuan Yuan Zhang, Qing Zhao, Zhen Hua Chao, Zhi Wen Jiang, Chen Chen Jiang","doi":"10.3892/ijmm.2025.5591","DOIUrl":null,"url":null,"abstract":"<p><p>Following the publication of the above article, an interested reader drew to the authors' attention that Figs. 3B and 4B contained western blot data (specifically, the MMP‑9 and Vimentin western blots in Figs. 3B and 4B, respectively) that were more similar than expected. Moreover, further strikingly similar data were also identified examining the western blot data within Fig. 4B and 4D, and also comparing the western blots in Figs. 1D, 3B, 4B and 4D with data featured in an article in the journal <i>Oncotarget</i> that was published subsequently to the above article, but which featured the first author (Pei Zhang) as an author in common. The authors were able to re‑examine their original data (which were also presented to the Editorial Office), and confirmed that the Vimentin data in Fig. 4B and the ZEB1 data in Fig. 4D were the same western bands as those featured for the MMP‑9 data in Fig. 3B and the Fibronectin data in Fig. 4B, respectively. These errors were made during the assembly of Fig. 4 (the data for MMP‑9 and Fibronectin were inadvertently duplicated in the figure). The corrected version of Fig. 4, now displaying the accurate experimental data for the Vimentin (Fig. 4B) and ZEB1 (Fig. 4D) blots in the CNE2Z and CNE2Z/DDP groups, is shown on the next page. Furthermore, regarding the issue of image duplication comparing between the above article published in 2014 and the one published in <i>Oncotarget</i> in 2015, the authors will contact the <i>Oncotarget</i> journal to handle the necessary corrections. The authors can confirm that the errors associated with this figure did not have any significant impact on either the results or the conclusions reported in this study, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of <i>International Journal of Molecular Medicine</i> for allowing them the opportunity to publish this Corrigendum; furthermore, they apologize to the readership of the Journal for any inconvenience caused. [International Journal of Molecular Medicine 33: 151‑159, 2014; DOI: 10.3892/ijmm.2013.1538].</p>","PeriodicalId":14086,"journal":{"name":"International journal of molecular medicine","volume":"56 4","pages":""},"PeriodicalIF":5.8000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12306597/pdf/","citationCount":"0","resultStr":"{\"title\":\"[Corrigendum] Epithelial‑mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.\",\"authors\":\"Pei Zhang, Hao Liu, Fei Xia, Qian Wen Zhang, Yuan Yuan Zhang, Qing Zhao, Zhen Hua Chao, Zhi Wen Jiang, Chen Chen Jiang\",\"doi\":\"10.3892/ijmm.2025.5591\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Following the publication of the above article, an interested reader drew to the authors' attention that Figs. 3B and 4B contained western blot data (specifically, the MMP‑9 and Vimentin western blots in Figs. 3B and 4B, respectively) that were more similar than expected. Moreover, further strikingly similar data were also identified examining the western blot data within Fig. 4B and 4D, and also comparing the western blots in Figs. 1D, 3B, 4B and 4D with data featured in an article in the journal <i>Oncotarget</i> that was published subsequently to the above article, but which featured the first author (Pei Zhang) as an author in common. The authors were able to re‑examine their original data (which were also presented to the Editorial Office), and confirmed that the Vimentin data in Fig. 4B and the ZEB1 data in Fig. 4D were the same western bands as those featured for the MMP‑9 data in Fig. 3B and the Fibronectin data in Fig. 4B, respectively. These errors were made during the assembly of Fig. 4 (the data for MMP‑9 and Fibronectin were inadvertently duplicated in the figure). The corrected version of Fig. 4, now displaying the accurate experimental data for the Vimentin (Fig. 4B) and ZEB1 (Fig. 4D) blots in the CNE2Z and CNE2Z/DDP groups, is shown on the next page. Furthermore, regarding the issue of image duplication comparing between the above article published in 2014 and the one published in <i>Oncotarget</i> in 2015, the authors will contact the <i>Oncotarget</i> journal to handle the necessary corrections. The authors can confirm that the errors associated with this figure did not have any significant impact on either the results or the conclusions reported in this study, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of <i>International Journal of Molecular Medicine</i> for allowing them the opportunity to publish this Corrigendum; furthermore, they apologize to the readership of the Journal for any inconvenience caused. [International Journal of Molecular Medicine 33: 151‑159, 2014; DOI: 10.3892/ijmm.2013.1538].</p>\",\"PeriodicalId\":14086,\"journal\":{\"name\":\"International journal of molecular medicine\",\"volume\":\"56 4\",\"pages\":\"\"},\"PeriodicalIF\":5.8000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12306597/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of molecular medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3892/ijmm.2025.5591\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/25 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of molecular medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3892/ijmm.2025.5591","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/25 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

在上述文章发表后,一位感兴趣的读者提请作者注意,图3B和图4B中包含的western blot数据(具体来说,分别是图3B和图4B中的MMP - 9和Vimentin western blot)比预期的更相似。此外,通过检查图4B和4D中的western blot数据,并将图1D、3B、4B和4D中的western blot数据与Oncotarget杂志上发表的一篇文章中的数据进行比较,还发现了进一步惊人的相似数据,该文章发表在上述文章之后,但第一作者(张培)是共同作者。作者能够重新检查他们的原始数据(也提交给编辑部),并确认图4B中的Vimentin数据和图4D中的ZEB1数据分别与图3B中的MMP - 9数据和图4B中的Fibronectin数据具有相同的西部带。这些错误是在图4的组装过程中产生的(图中无意中重复了MMP - 9和Fibronectin的数据)。图4的更正版本显示了CNE2Z组和CNE2Z/DDP组中Vimentin(图4B)和ZEB1(图4D)的准确实验数据,见下一页。此外,关于上述2014年发表的文章与2015年在Oncotarget发表的文章存在图像重复的问题,作者将联系Oncotarget期刊进行必要的修改。作者可以确认,与该数字相关的错误对本研究的结果或结论没有任何重大影响,并且所有作者都同意发布此勘误表。作者感谢《国际分子医学杂志》的编辑允许他们有机会发表本勘误表;此外,他们对给《华尔街日报》的读者造成的任何不便表示歉意。[j]国际分子医学杂志33:151 - 159,2014;DOI: 10.3892 / ijmm.2013.1538]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

[Corrigendum] Epithelial‑mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.

[Corrigendum] Epithelial‑mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.

Following the publication of the above article, an interested reader drew to the authors' attention that Figs. 3B and 4B contained western blot data (specifically, the MMP‑9 and Vimentin western blots in Figs. 3B and 4B, respectively) that were more similar than expected. Moreover, further strikingly similar data were also identified examining the western blot data within Fig. 4B and 4D, and also comparing the western blots in Figs. 1D, 3B, 4B and 4D with data featured in an article in the journal Oncotarget that was published subsequently to the above article, but which featured the first author (Pei Zhang) as an author in common. The authors were able to re‑examine their original data (which were also presented to the Editorial Office), and confirmed that the Vimentin data in Fig. 4B and the ZEB1 data in Fig. 4D were the same western bands as those featured for the MMP‑9 data in Fig. 3B and the Fibronectin data in Fig. 4B, respectively. These errors were made during the assembly of Fig. 4 (the data for MMP‑9 and Fibronectin were inadvertently duplicated in the figure). The corrected version of Fig. 4, now displaying the accurate experimental data for the Vimentin (Fig. 4B) and ZEB1 (Fig. 4D) blots in the CNE2Z and CNE2Z/DDP groups, is shown on the next page. Furthermore, regarding the issue of image duplication comparing between the above article published in 2014 and the one published in Oncotarget in 2015, the authors will contact the Oncotarget journal to handle the necessary corrections. The authors can confirm that the errors associated with this figure did not have any significant impact on either the results or the conclusions reported in this study, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of International Journal of Molecular Medicine for allowing them the opportunity to publish this Corrigendum; furthermore, they apologize to the readership of the Journal for any inconvenience caused. [International Journal of Molecular Medicine 33: 151‑159, 2014; DOI: 10.3892/ijmm.2013.1538].

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International journal of molecular medicine
International journal of molecular medicine 医学-医学:研究与实验
CiteScore
12.30
自引率
0.00%
发文量
124
审稿时长
3 months
期刊介绍: The main aim of Spandidos Publications is to facilitate scientific communication in a clear, concise and objective manner, while striving to provide prompt publication of original works of high quality. The journals largely concentrate on molecular and experimental medicine, oncology, clinical and experimental cancer treatment and biomedical research. All journals published by Spandidos Publications Ltd. maintain the highest standards of quality, and the members of their Editorial Boards are world-renowned scientists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信